TY - JOUR
T1 - Chronic Hyponatremia Potentiates Innate Anxiety-Like Behaviors Through the Dysfunction of Monoaminergic Neurons in Mice
AU - Fujisawa, Haruki
AU - Magara, Nobuhiko
AU - Nakayama, Shogo
AU - Fuse, Sachiho
AU - Iwata, Naoko
AU - Hasegawa, Masaya
AU - Kubota, Hisayoshi
AU - Shoji, Hirotaka
AU - Hattori, Satoko
AU - Hagihara, Hideo
AU - Fujigaki, Hidetsugu
AU - Seino, Yusuke
AU - Mouri, Akihiro
AU - Miyakawa, Tsuyoshi
AU - Nabeshima, Toshitaka
AU - Suzuki, Atsushi
AU - Sugimura, Yoshihisa
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2025.
PY - 2025/9
Y1 - 2025/9
N2 - Hyponatremia is the most common clinical electrolyte disorder. Once thought to be asymptomatic in response to adaptation by the brain, recent evidence suggests that chronic hyponatremia (CHN) may induce neurological manifestations, including psychological symptoms. However, the specific psychological symptoms induced by CHN, the mechanisms underlying these symptoms, and their potential reversibility remain unclear. Therefore, this study aimed to determine whether monoaminergic neurotransmission is associated with innate anxiety-like behaviors potentiated by CHN in a mouse model of CHN secondary to the syndrome of inappropriate antidiuresis. In the present study, using a mouse model of the syndrome of inappropriate antidiuresis presenting with CHN, we showed that the sustained reduction of serum sodium ion concentrations potentiated innate anxiety-like behaviors in the light/dark transition and open field tests. We also found that serotonin and dopamine levels in the amygdala were significantly lower in mice with CHN than in controls. Additionally, phosphorylation of extracellular signal-regulated kinase (ERK) in the amygdala was significantly reduced in mice with CHN. Notably, after correcting for CHN, the increased innate anxiety-like behaviors, decreased serotonin and dopamine levels, and reduced phosphorylation of ERK in the amygdala were normalized. These findings further underscore the importance of treating CHN and highlight potential therapeutic strategies for alleviating anxiety in patients with CHN, which will improve their quality of life.
AB - Hyponatremia is the most common clinical electrolyte disorder. Once thought to be asymptomatic in response to adaptation by the brain, recent evidence suggests that chronic hyponatremia (CHN) may induce neurological manifestations, including psychological symptoms. However, the specific psychological symptoms induced by CHN, the mechanisms underlying these symptoms, and their potential reversibility remain unclear. Therefore, this study aimed to determine whether monoaminergic neurotransmission is associated with innate anxiety-like behaviors potentiated by CHN in a mouse model of CHN secondary to the syndrome of inappropriate antidiuresis. In the present study, using a mouse model of the syndrome of inappropriate antidiuresis presenting with CHN, we showed that the sustained reduction of serum sodium ion concentrations potentiated innate anxiety-like behaviors in the light/dark transition and open field tests. We also found that serotonin and dopamine levels in the amygdala were significantly lower in mice with CHN than in controls. Additionally, phosphorylation of extracellular signal-regulated kinase (ERK) in the amygdala was significantly reduced in mice with CHN. Notably, after correcting for CHN, the increased innate anxiety-like behaviors, decreased serotonin and dopamine levels, and reduced phosphorylation of ERK in the amygdala were normalized. These findings further underscore the importance of treating CHN and highlight potential therapeutic strategies for alleviating anxiety in patients with CHN, which will improve their quality of life.
KW - Amygdala
KW - Anxiety
KW - Dopamine
KW - ERK
KW - Hyponatremia
KW - Serotonin
UR - https://www.scopus.com/pages/publications/105005098454
UR - https://www.scopus.com/pages/publications/105005098454#tab=citedBy
U2 - 10.1007/s12035-025-05024-y
DO - 10.1007/s12035-025-05024-y
M3 - Article
C2 - 40366558
AN - SCOPUS:105005098454
SN - 0893-7648
VL - 62
SP - 12078
EP - 12093
JO - Molecular Neurobiology
JF - Molecular Neurobiology
IS - 9
ER -